NCT05912231View on ClinicalTrials.gov

Ultrahypofractionation and Normal Tissue Toxicity

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

September 17, 2025

Study Completion Date

September 17, 2025

Conditions
Breast CancerBreast Cancer FemaleBreast Cancer Stage IIBreast Cancer Stage IIIMyocardial Fibrosis
Interventions
RADIATION

Accelerated Proton Beam Radiation Therapy (PBT)

per protocol

RADIATION

Accelerated Photon Radiation Therapy (XRT)

per protocol

Trial Locations (1)

02215

RECRUITING

Massachusetts General Hospital Cancer Center, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

American Society of Clinical Oncology

OTHER

lead

Massachusetts General Hospital

OTHER